IHT Wealth Management’s Intelligent Bio Solutions INBS Stock Holding History

IHT Wealth Management’s Portfolio INBS Stock Details INBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8	Closed	-$13K	–	890
2022 Q2	$13K	Hold	8	–	–	﹤0.01%	729
2022 Q1	$16K	Buy	+8	New	+$18.4K	﹤0.01%	760

Other funds holding INBS

GAM

Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

IHT Wealth Management's INBS Position: Q3 2022 in Review

IHT Wealth Management sold out of Intelligent Bio Solutions (INBS) in Q3 2022, closing a stake of 8 shares — an estimated $13K sold.

IHT Wealth Management first reported a position in INBS in Q1 2022 and held it in 2 quarters. The position peaked at $16K in Q1 2022. 8 funds tracked by Wall St. Rank hold INBS as of Q3 2022.

IHT Wealth Management reported no remaining Intelligent Bio Solutions position as of Q3 2022 after selling out during the quarter.
IHT Wealth Management sold 8 Intelligent Bio Solutions shares in Q3 2022, an estimated $13K.
IHT Wealth Management first reported a position in Intelligent Bio Solutions in Q1 2022 and held it in 2 quarters.
IHT Wealth Management's Intelligent Bio Solutions position peaked at $16K in Q1 2022.
8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q3 2022.

Based on IHT Wealth Management's 13F filing for Q3 2022, filed 22 Nov 2022.